Unknown

Dataset Information

0

Genetic deletion of nitric oxide synthase 2 ameliorates Parkinson's disease pathology and neuroinflammation in a transgenic mouse model of synucleinopathy.


ABSTRACT: Studies of mouse models of Alzheimer's disease (AD) have demonstrated that nitric oxide synthase 2 (NOS2) is involved in AD pathology. However, the effects of NOS2 on the pathology of Parkinson's disease (PD) are not well studied. To address this gap, we examined the impact of NOS2 on disease-associated phenotypes in a mouse model of PD. Transgenic mice carrying the A53T mutation of α-synuclein (SynA53T) and newly generated double transgenic mice with deletion of NOS2 (SynA53T/NOS2-/-) were used. Compared with SynA53T mice, the loss of nos2 decreased α-synuclein phosphorylation at serine 129 and reduced α-synuclein-induced microglial and astrocyte activation in SynA53T/NOS-/- mice. Additionally, neuroinflammation-related gene clusters in the deep mesencephalic nucleus (DpMe) were altered in SynA53T/NOS-/- mice compared with SynA53T mice. Taken together, our results suggest that deletion of nos2 alleviates α-synuclein pathology and α-synuclein-associated neuroinflammatory responses in the brain.

SUBMITTER: Kim J 

PROVIDER: S-EPMC9841612 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Genetic deletion of nitric oxide synthase 2 ameliorates Parkinson's disease pathology and neuroinflammation in a transgenic mouse model of synucleinopathy.

Kim Jieun J   Han Jung-Youn JY   Lee Yujeong Y   Kim Kipom K   Choi Young Pyo YP   Chae Sehyun S   Hoe Hyang-Sook HS  

Molecular brain 20230116 1


Studies of mouse models of Alzheimer's disease (AD) have demonstrated that nitric oxide synthase 2 (NOS2) is involved in AD pathology. However, the effects of NOS2 on the pathology of Parkinson's disease (PD) are not well studied. To address this gap, we examined the impact of NOS2 on disease-associated phenotypes in a mouse model of PD. Transgenic mice carrying the A53T mutation of α-synuclein (Syn<sup>A53T</sup>) and newly generated double transgenic mice with deletion of NOS2 (Syn<sup>A53T</s  ...[more]

Similar Datasets

| S-EPMC3586978 | biostudies-literature
| S-EPMC4768134 | biostudies-literature
2021-01-18 | GSE164521 | GEO
2023-06-01 | PXD040726 | Pride
| S-EPMC509160 | biostudies-other
| S-EPMC2630458 | biostudies-literature
| S-EPMC6370721 | biostudies-literature
| S-EPMC2884648 | biostudies-literature
| S-EPMC1987713 | biostudies-literature
| S-EPMC2758698 | biostudies-literature